Microplastics and Misinformation: What Science Really Says
November 12, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Synonyms :
Class :
Brand Name :
Synonyms :
Class :
They may increase the thrombogenic effect when combined with asparaginase Products
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may increase the toxicity of each other through pharmacodynamic synergism
may diminish the serum concentration
may reduce the levels of serum concentration of hormonal contraceptives
aprepitant: they may diminish the serum concentration of hormonal contraceptives
asunaprevir: they may diminish the serum concentration of hormonal contraceptives
atazanavir: they may diminish the serum concentration of hormonal contraceptives
brigatinib: they may diminish the serum concentration of hormonal contraceptives
carfilzomib: they may increase the thrombogenic effect of hormonal contraceptives
cladribine: they may decrease the therapeutic effect of hormonal contraceptives
cobicistat: they may diminish the serum concentration of hormonal contraceptives
efavirenz: they may diminish the serum concentration of hormonal contraceptives
elagolix: they may diminish the therapeutic effect of hormonal contraceptives
exenatide: they may diminish the therapeutic effect of hormonal contraceptives
felbamate: they may diminish the serum concentration of hormonal contraceptives
fosaprepitant: they may diminish the serum concentration of hormonal contraceptives
griseofulvin: they may diminish the serum concentration of hormonal contraceptives
ivosidenib: they may diminish the serum concentration of hormonal contraceptives
ixazomib: they may diminish the serum concentration of hormonal contraceptives
lixisenatide: they may decrease the therapeutic effect of hormonal contraceptives
mavacamten: they may diminish the serum concentration of hormonal contraceptives
mifepristone: they may decrease the therapeutic effect of hormonal contraceptives
mycophenolate mofetil: they may diminish the serum concentration of hormonal contraceptives
nirmatrelvir and ritonavir: they may diminish the serum concentration of hormonal contraceptives
oxcarbazepine: they may diminish the serum concentration of hormonal contraceptives
pitolisant: they may diminish the serum concentration of hormonal contraceptives
protease inhibitors: they may diminish the serum concentration of hormonal contraceptives
tazemetostat: they may diminish the serum concentration of hormonal contraceptives
cannabidiol: they may diminish the serum concentration of hormonal contraceptives
may diminish the serum concentration of CYP3A4 Inducers
may diminish the serum concentration of each other when combined
it increases the adverse effects caused due to eptinezumab
in combination with ofatumumab, they increase the activity of thrombogenesis
encorafenib: they may diminish the serum concentration of hormonal contraceptives
mobocertinib: they may diminish the serum concentration of hormonal contraceptives
omaveloxolone: they may diminish the serum concentration of hormonal contraceptives
pexidartinib: they may diminish the serum cocentration of hormonal contraceptives
tranexamic acid: they may increase the thrombogenic effect of hormonal contraceptives
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the serum concentration of Vitamin K Antagonists
may increase the levels of serum concentration of vitamin K antagonists
may increase the levels of serum concentration of vitamin K antagonists
may increase the levels of serum concentration of vitamin K antagonists
may increase the levels of serum concentration of vitamin K antagonists
may increase the levels of serum concentration of vitamin K antagonists
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
It may diminish the effects when combined with metformin by pharmacodynamic antagonism
it may diminish the metabolism when combined with diosmin
Combining ethinylestradiol with pranlukast may cause a reduction in the ethinylestradiol’s metabolism
when bromazepam and ethinylestradiol are used together, there is a potential reduction in the bromazepam's metabolism
When ethinylestradiol is used together with adenine, this leads to a reduction in the ethinylestradiol ’s metabolism
When ethinylestradiol is used together with clomocycline, this leads to reduction in concentration serum of clomocycline
the effect of ethinylestradiol is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
when both drugs are combined, there may be a decreased effects of ethinylestradiol by receptor binding competition  
when both drugs are combined, there may be a decreased effect of ethinylestradiol by altering intestinal flora 
when both drugs are combined, there may be a decreased effect of ethinylestradiol by altering intestinal flora  
demeclocycline may interfere with the intestinal flora and reduce the effects of conjugated estrogens (oral form of hormones)
doxycycline may interfere with the intestinal flora and reduce the effects of conjugated estrogens (oral form of hormones)
lansoprazole amoxicillin and clarithromycin
when amoxicillin combines with ethinylestradiol it decreases the effects of action of the drug and results in changes of intestinal flora
amoxicillin and clavulanate potassium
when amoxicillin combines with ethinylestradiol it decreases the effects of action of the drug and results in changes of intestinal flora
omeprazole amoxicillin and clarithromycin
when both drugs are combined, there may be a decreased effect of the drug's action by decreasing renal clearance
when both drugs are combined, there may be a decreased effect of the drug's action by decreasing renal clearance
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
protease inhibitors may reduce the level of serum concentration of hormonal contraceptives
CYP3A4 Inducers may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may increase the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
may decrease the levels of serum concentration
may increase the levels of serum concentration
may increase the levels of serum concentration
It may enhance the thrombogenic activities when combined with sotrovimab
etravirine: they may diminish the serum concentration of hormonal contraceptive
flibanserin: they may enhance the serum concentration of hormonal contraceptives
thalidomide: they may increase the thrombogenic effect of hormonal contraceptives
voriconazole: they may enhance the serum concentration of hormonal contraceptives
It may diminish the effect when combined with lixisenatide by inhibiting gastrointestinal absorption
When ethinylestradiol is aided by hesperetin, it reduces hesperetin’s metabolism
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
CYP3A4 inducers decrease the concentration of hormonal contraceptives in the serum
topiramate decreases the concentration of hormonal contraceptives in the serum
perampanel decreases the concentration of hormonal contraceptives in the serum
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
